Efficacy of intensive, high-dose anthracycline-based therapy in intermediate- and high-grade non-Hodgkin's lymphomas.
Zuckerman
K S
KS
Division of Hematology-Oncology, University of Alabama at Birmingham 35294.
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis
D000903:Antibiotics, Antineoplastic